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ReviewAID: How Does It Aid Antibody Diversity?
SHM introduces point mutations in V genes without tem-Tasuku Honjo,1,* Masamichi Muramatsu,1
and Sidonia Fagarasan2 plate, whereas GC does so with pseudo V genes as
template (Arakawa and Buerstedde, 2004). When SHM1Department of Medical Chemistry and
Molecular Biology is coupled with selection by limited amounts of antigen,
affinity maturation takes place by enriching high-affinityGraduate School of Medicine
Kyoto University Ig-producing cells. CSR is a region-specific recombina-
tion that switches isotypes from IgM to the other iso-Yoshida Sakyo-Ku, Kyoto 606-8501
2 RIKEN Research Center for Allergy and Immunology types, such as IgG and IgE, adding diverse effector
functions to Ig with a given antigen specificity. CSRTsurumi-ku, Yokohama
Kanagawa 230-0045 takes place in S regions of the CH locus and proceeds
by cleaving, juxtaposing, and joining S and one of theJapan
other S regions that are located 5 to each CH gene. CSR
results in looping-out deletion of the intervening DNA
segment from the chromosome and bringing the re-Activation-induced cytidine deaminase (AID) is an es-
sential enzyme to regulate class switch recombination arranged V gene from upstream of the C gene to the
proximity of the different CH gene.(CSR), somatic hypermutation (SHM), and gene con-
version (GC). AID is known to be required for DNA Antigen-induced genetic alterations are thus essential
to generate antigen-specific antibodies. Enzymes re-cleavage of S regions in CSR. However, its molecular
mechanism is a focus of extensive debate. RNA editing sponsible for the three genetic alteration reactions had
not been revealed for about a decade after the discoveryhypothesis postulates that AID edits yet unknown
mRNA to generate specific endonucleases for CSR of RAG-1 and RAG-2, until activation-induced cytidine
deaminase (AID) was found to be essential to both CSRand SHM. By contrast, DNA deamination hypothesis
assumes that AID deaminates cytosine in DNA, fol- and SHM (Muramatsu et al., 2000; Revy et al., 2000).
Subsequently, AID was shown to be responsible for GClowed by DNA cleavage by base excision repair en-
zymes. We discuss available evidence for the two pro- as well (Arakawa et al., 2002). In this review, we focus
on the molecular mechanism of how AID regulates threeposed models. Recent findings, namely requirement
of protein synthesis for DNA breakage and dispens- genetic alterations required for antigen-specific Ig syn-
thesis.ability of U removal activity of uracil DNA glycosylase,
force us to reconsider DNA deamination hypothesis.
Molecular and Physiological Properties of AID
Isolation, Expression, and Structure of AID
Introduction AID cDNA was isolated from a murine B lymphoma line
Generation of immunoglobulin (Ig) diversity depends on CH12F3-2 by subtractive cDNA hybridization using
four types of genetic alteration mechanism in Ig loci, mRNAs from class switch-stimulated and nonstimulated
namely VDJ recombination, somatic hypermutation CH12F3-2 cells (Muramatsu et al., 1999). AID mRNA is
(SHM), gene conversion (GC), and class switch recombi- found only in activated B cells, most prominently in the
nation (CSR). The basic repertoire of Ig variable region germinal center B cells. AID mRNA encodes a protein
(V) diversity is generated by VDJ recombination, which of 198 amino acid residues containing a unique cytidine
is tightly coupled with the differentiation steps of B lym- deaminase motif at residues 55–94, which includes three
phocytes (Sekiguchi et al., 2004). In bone marrow, B essential residues (H56, C87, and C90) for zinc binding
lymphocyte progenitors differentiate by stepwise as- and catalytic activity. These residues are highly con-
sembly of subexon DNA segments of the heavy chain served by all members of the cytidine deaminase family,
(H) V genes, followed by those of the light chain V genes. including metabolic cytidine deaminase in E. coli. The
VDJ recombination is a site-specific recombination reg- authologue of AID is found in vertebrates but not in
ulated by two recombinases, RAG-1 and RAG-2, and nonvertebrates. The amino acid sequence of AID has
precisely programmed in parallel with B lymphocyte dif- the strongest homology with that of apolipoprotein (apo)
ferentiation (Oettinger et al., 1990; Schatz et al., 1989). B mRNA editing catalytic polypeptide 1 (APOBEC-1),
VDJ recombination is responsible for generation of a a well-characterized RNA editing enzyme of apoB100
huge repertoire of immunoglobulin V, including those mRNA that encodes the cholesterol carrier protein in
that are not particularly useful for the body defense. All low-density lipoprotein (LDL) (Teng et al., 1993). APO-
B lymphocytes that successfully completed VDJ recom- BEC-1 recognizes the structure of apoB100 mRNA
bination express IgM on surface and migrate to the sec- through a cofactor called APOBEC-1 complementation
ondary lymphoid organs, where they are activated by factor (ACF) (Mehta et al., 2000), which guides the APO-
encountering antigens. BEC-1 catalytic center to the specific cytosine (C) at
Antigen stimulation induces the other three types of position 6666. APOBEC-1 converts this C to uracil (U)
genetic alterations, namely SHM, GC, and CSR, in acti- and generates apoB48 mRNA that encodes the chylomi-
vated B cells (Honjo et al., 2002; Stavnezer et al., 2004). cron protein component, a carrier of triglyceride. Both
APOBEC-1 and AID form dimer (Lau et al., 1994; Ta et
al., 2003).*Correspondence: honjo@mfour.med.kyoto-u.ac.jp
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AID Is Essential and Sufficient for CSR and SHM protrusion of isolated lymphoid follicles (Fagarasan et
al., 2002).The physiological function of AID is clearly demon-
strated by studies on AID-deficient animals and patients The absence of normal hypermutated intestinal IgA
causes a profound disregulation of the gut microflora,(Muramatsu et al., 2000; Revy et al., 2000). AID-deficient
mice show the complete loss of class switching and especially an excessive proliferation of anaerobic bacte-
ria. The anaerobes detected in all segments of AID/accumulation of IgM in sera and feces. Patients with an
autosomal recessive hereditary disease called hyper- small intestine are nonpathogenic, commensal strains
usually found in flora of the large intestine (FagarasanIgM syndrome type 2 (HIGM2) have severe defects in
class switching. Genetic linkage analysis of the disease et al., 2002). Among them, the major population is repre-
sented by segmented filamentous bacteria, strict anaer-locus using polymorphic markers has revealed that the
mutation is mapped on chromosome 12p13, which coin- obes that cannot be cultured, at least with available
microbiogical techniques, and strongly attach to thecided with the human AID gene locus determined by the
FISH analysis (Muto et al., 2000). Subsequent molecular mucosal epithelium (Suzuki et al., 2004). An antibiotic
treatment inhibiting anaerobe expansion or reconstitu-studies demonstrated that all HIGM2 patients have mu-
tations in the AID gene, and all these mutated AID cDNAs tion of IgA production in AID/ small intestine recovers
the normal composition of gut flora and abolishes bothare recently shown to be defective in CSR by in vitro
assays (see below) (Ta et al., 2003). local and systemic activation of the immune system
(Fagarasan et al., 2002; Suzuki et al., 2004). Thus, IgAThe B lymphocytes from HIGM2 patients and AID-
deficient mice are unable to switch isotypes by in vitro secreted into the gut lumen appears to function not
only for protection against pathogenic bacterial or viralstimulation. Surprisingly, AID-deficient memory B cells
of HIGM2 patients do not have SHM, and repeated anti- antigens but also for the homeostasis of the nonpatho-
genic gut flora, which is essential to prevent overstimula-gen stimulation of AID-deficient mice do not show accu-
mulation of mutations in the antigen-specific V region tion of the nonmucosal immune system (Fagarasan and
Honjo, 2003). Unmutated IgMs, although secreted into(Muramatsu et al., 2000; Revy et al., 2000).
Ectopic expression of AID induces class switching the gut lumen, cannot prevent the excessive and aber-
rant expansion of anaerobes.and hypermutation in non-B cells, such as fibroblasts
(Okazaki et al., 2002; Yoshikawa et al., 2002), hybrido- Tumorgenesis by Constitutive Expression of AID
Transgenic mice with AID cDNA under the control of themas (Martin et al., 2002; Martin and Scharff, 2002b),
and T cells (Okazaki et al., 2002), which carry artificial chicken -actin promoter develop T cell tumors and die
by 85 weeks without an exception (Okazaki et al., 2003).constructs for measuring CSR and SHM. DT40 chicken
B cells that mutated the AID gene cannot undergo GC, The onset of tumors varies from 4 to 40 weeks, de-
pending on the copy numbers of the transgene. By sur-which can be recovered by transfection of the AID cDNA
(Arakawa et al., 2002). These results clearly demonstrate face phenotype, T cell tumors appear to originate from
either thymic or peripheral T cells. In rare cases, tumorsthat AID is essential and sufficient to all three different
genetic alterations induced by antigen stimulation of B develop in lung, liver, and muscle tissues (our unpub-
lished data). To our surprise, no B lymphomas have beencells. The other enzymes and cofactors are probably
expressed ubiquitously. detected in the AID-transgenic mice.
In both types of T lymphomas, a large number ofPhenotypes in AID-Deficient Mice
As compared with RAG-2/ mice, AID/ mice are rela- mutations accumulate in the V gene (103) but very infre-
quently in the C gene (104) of the T cell receptor, withtively healthy under the SPF condition and resistant to
infection with a virulent strain of influenza virus (Harada a distribution profile of mutations reminiscent of SHM
accumulation in Ig V genes. The mutation accumulationet al., 2003). However, AID-deficient mice are more sus-
ceptible to secondary infection with higher doses, indi- is also identified in the c-myc gene. Mutation target
genes are selective because there are many transcrip-cating that nonmutated IgM has significant protection
capacity against low-dose virus but tailored Igs with tionally active genes, which do not have mutations. No
common chromosomal translocation other than spo-SHM and CSR are important for protection from infec-
tion with higher-dose virus. radic one is found in these tumors (Okazaki et al., 2003).
Therefore, mutation accumulation leading to tumor de-HIGM2 patients suffer from recurrent infections, which
velopment is not solely related with deficiency in DNAcause hyperthrophy of lymph nodes and enlarged ger-
repair genes but also to an uncontrolled AID activity,minal centers (Revy et al., 2000). AID-deficient mice also
thus identifying AID as the first active mutator in verte-have enlarged germinal centers (Muramatsu et al., 2000)
brates.and accumulation of activated IgM B cells and IgM
plasma cells in all lymphoid tissues, but especially in
the gut lamina propria (Fagarasan et al., 2002). Accumu- Molecular Mechanism for Regulation of CSR
lation of IgM B cells and plasma cells in the intestine and SHM by AID
of AID/ mice is explained by (1) blockade of in situ AID Involvement in DNA Cleavage
class switching in the gut lymphoid tissues of AID/ The molecular mechanism how AID regulates CSR,
mice, where local IgM B cells ordinarily switch prefer- SHM, and GC is a puzzling and fascinating question to
entially to IgA and differentiate to IgA plasma cells (Fa- scientists in broad disciplines (Durandy and Honjo, 2001;
garasan et al., 2001), and (2) sustained activation of the Maizels, 2000; Martin and Scharff, 2002a; Reynaud et
immune system due to the absence of intestinal IgA, al., 2003). Although these DNA alterations are distinct
causing continuous recruitment of immune cells to gut, in the overall mechanism and properties of the products,
the initiation step of the three reactions is similar;which leads to hyperthrophy of Peyer’s patches and
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Figure 1. Duplication and Deletion in an Inversion-Type CSR Substrate
(A) Staggered nicking on both strands of DNA; (B) 3 or 5 overhang is processed to make it blunt end by exonuclease or DNA synthesis,
respectively; (C) inversion-type recombination results in duplication or deletion at junctions. The inversion-type substrate is designed to select
out deletion products (Chen et al., 2001).
namely, all depend on the DNA cleavage. There is no The direct evidence to support involvement of AID in
the DNA cleavage rather than the repair was obtained byquestion about requirement of double-strand breakages
(DSBs) in CSR. Study on an artificial inversion-type sub- experiments using focus formation of a phosphorylated
form of histone H2AX (-H2AX) in the IgH locus as astrate of CSR strongly indicates that two single-strand
breakages (SSBs) are triggering events in CSR (Chen et marker of DSB (Petersen et al., 2001). Cleaved ends of
DNA may be monitored by ATM/ATR or DNA-PKcs,al., 2001). This is because inversion products of CSR
often contain duplication or deletion at the recombina- which phosphorylates histone H2AX, necessary for pro-
tection of DNA ends and for recruitment of many repairtion junctions (Figure 1). Two SSBs each on a separate
strand (staggered nicks) generate 3 or 5 overhang at enzymes (Celeste et al., 2002). Since H2AX-deficient
mice have severely reduced CSR, -H2AX focus forma-the cleaved ends, which have to be repaired by exo-
nucleolytic digestion or gap-filling DNA synthesis. CSR tion is probably an important intermediate event of CSR.
-H2AX focus formation is induced at the IgH locus ofis a region-specific recombination that requires NHEJ
to repair cleaved ends (Casellas et al., 1998; Manis et spleen B cells upon class switch stimulation (Petersen
et al., 2001). However, such focus formation as well asal., 1998, 2002; Rolink et al., 1996). Since one of the
recombination junctions is looped out during normal CSR is defective in AID-deficient B cells stimulated for
class switching, which indicates that DSB in the IgHCSR, identification of deletion or duplication is only pos-
sible by the inversion-type substrate. locus is dependent on the AID protein.
Hypotheses for the DNA Cleavage MechanismSHM can be easily explained by SSB and error-prone
DNA repair (Diaz et al., 2001; Faili et al., 2002; Yavuz et Two models are proposed for DNA cleavage by AID, as
schematically depicted in Figure 2. RNA editing hypoth-al., 2002; Zan et al., 2001; Zeng et al., 2001). Although
DSB coupled with homologous recombination was re- esis is originally proposed by evolutionary conservation
between AID and RNA editing enzyme APOBEC-1cently proposed as the mechanism of SHM (Papavasi-
liou and Schatz, 2000; Zan et al., 2003), DT40 cells with (Honjo et al., 2002; Muramatsu et al., 2000). RNA editing
hypothesis predicts that a complex of AID and its cofac-a loss-of-function mutation of XRCC2/3 that is essential
to homologous recombination show reduced GC and tors recognizes an unidentified mRNA, and AID deami-
nates C to U at a specific position of the mRNA. Thestrongly enhanced SHM (Sale et al., 2001), suggesting
that homologous recombination is involved in GC but edited mRNA encodes a DNA endonuclease that
cleaves the V or S region DNA. Since AID expression innot in SHM. GC is probably mediated by homologous
recombination with pseudogenes, but SHM may not de- non-B cells (fibroblasts, T cells, hybridoma, and CHO
cells) can initiate the DNA cleavage for CSR and SHMpend on any type of recombination. Thus, the three
reactions that depend on AID have different repair mech- (Martin et al., 2002; Okazaki et al., 2002; Yoshikawa et
al., 2002), the RNA editing hypothesis postulates thatanisms after DNA cleavage.
Immunity
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Figure 2. Two Models for AID Function in CSR and SHM
Detailed mechanisms are explained in the text.
target mRNA as well as cofactor proteins are expressed of AID induces widespread mutations in the E. coli ge-
nome (Diaz et al., 2003; Petersen-Mahrt et al., 2002;more or less ubiquitously. The cofactors may recognize
the structure of the target mRNA, just like ACF recog- Ramiro et al., 2003; Sohail et al., 2003; Ta et al., 2003).
Since it is unlikely that AID cofactors and target mRNAnizes the structure of apoB100 mRNA.
On the other hand, Neuberger and his colleagues have are conserved between E. coli and mammals, the obser-
vation strongly suggests that AID directly deaminatesproposed that AID deaminates C in target DNA and
generates U:G mismatch base pair (DNA deamination C in E. coli DNA. DNA deamination hypothesis gained
further support by in vitro experiments showing thathypothesis) (Petersen-Mahrt et al., 2002; Di Noia and
Neuberger, 2002). Such U:G pairs are assumed to be single-strand DNA can be deaminated by AID (Bransteit-
ter et al., 2003; Chaudhuri et al., 2003; Dickerson et al.,eliminated and repaired by the base excision repair
pathway, which are evolutionarily conserved from E. coli 2003; Pham et al., 2003; Sohail et al., 2003; Yu et al.,
2004). However, it should be noted that in vitro DNAto mammals. The enzymes involved in the base excision
repair pathway are uracil DNA glycosylase or uracil- deamination activity of AID is very weak. The amount
of AID required to deaminate single-strand DNA in vitroN-glycosylase (UNG), apurinic/apyrimidinic (AP) endo-
nuclease, and DNA polymerase . UNG hydrolyzes U is in far excess as compared with in vivo. Furthermore,
not only AID but also a bona fide RNA editing enzymebase in DNA, generating an AP site. AP endonuclease
then introduces SSB at the AP site, which triggers repair APOBEC-1 introduces mutations in E. coli. However,
overexpression of APOBEC-1 in B cells does not induceDNA synthesis by DNA polymerase . DNA deamination
model also postulates that SHM can be induced without SHM or CSR (Eto et al., 2003; Fugmann et al., 2004).
Induction of mutations in E. coli is also shown by otherDNA cleavage, by replication-coupled mutation after
generation of U (Petersen-Mahrt et al., 2002; Di Noia APOBEC-1 family members, whose functions in vivo
are not yet clear (Harris et al., 2002). Obviously, DNAand Neuberger, 2002) (Figure 2).
Supporting Evidence for DNA deamination by AID in E. coli and in vitro has no specific-
ity in primary sequences of DNA, which is required forDeamination Hypothesis
DNA Deamination In Vitro and in E. coli. DNA deamina- SHM and CSR. Since AID requires cofactors for recogni-
tion of substrates (see below), it may be the cofactortion hypothesis is supported by the fact that expression
Review
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but not AID that determines the substrate specificity by cycloheximide, although it did not block -H2AX fo-
cus formation induced by  ray irradiation. The fact thatfor DNA or RNA. These findings suggest that the DNA
deamination reaction in E. coli and in vitro may not AID-dependent DNA cleavage in CSR requires new pro-
tein synthesis is consistent with RNA editing hypothesisnecessarily represent the real function of AID.
Defects of CSR and SHM in UNG Deficiency. CSR is but cannot be explained by direct deamination of DNA
by AID because base excision repair enzymes are ubiq-severely defective in UNG-deficient mouse (Rada et al.,
2002) and human B cells (Imai et al., 2003). UNG/ B uitously expressed.
Functional Homology of AID and APOBEC-1. AID andcells stimulated in vitro show about one order magnitude
less efficient switching, but serum IgG and IgA levels APOBEC-1 are homologous not only in structure but
also in their functional properties. As described below,are not strikingly reduced, indicating that UNG plays a
role in CSR but apparently not an essential one. In vitro- both appear to require cofactors for recognition of sub-
strates and both form dimer. Another interesting featurestimulated B cells of UNG-deficient patients show more
severe defects in CSR. The frequency of SHM is not of AID that strongly indicates functional similarity to
APOBEC-1 was also recently reported (Ito et al., 2004).reduced but the base specificity is perturbed (higher
transition at G/C) in UNG/ mouse B cells and DT40 APOBEC-1 is known to be a nuclear shuttling protein
(Chester et al., 2003). The N-terminal and C-terminalchicken B cells expressing a specific UNG inhibitor, Ugi
(Di Noia and Neuberger, 2002). Similar base specificity regions of APOBEC-1 interact with a nuclear transporter
(importin) and nuclear exclusion machinery, respec-change is also confirmed in patients with UNG mutations
(Imai et al., 2003). Intriguingly, UNG-deficient mice do tively. The APOBEC-1/ACF complex is transported by
importin into the nucleus, where it recognizes and editsnot show other phenotypes, except for slow develop-
ment of B cell lymphomas (50% survival at 101 weeks target mRNA. Then, the complex is exported to the cyto-
plasm where edited mRNA is translated. Ito et al. (2004)for UNG/ versus 116 weeks for UNG/) (Nilsen et al.,
2003). In addition, the overall mutation rate in UNG/ showed that AID also contains an N-terminal nuclear
localization signal and a C-terminal nuclear exclusionmice is only marginally increased as compared to
UNG/ mice (Nilsen et al., 2000). These results indicate signal. The C terminus truncation protein of AID accumu-
lates in the nucleus. An antibiotic, leptomycin B, blocksthat UNG activity to remove U can be compensated by
other enzymes that recognize U:G mismatch pairs, such nuclear exclusion machinery and thus causes accumu-
lation of AID in the nucleus. These observations showas SMUG1 and MSH2/6 (Krokan et al., 2002; Wang et
al., 1999). Then why is the phenotype of UNG null muta- that AID has evolutionarily conserved structure and
function of a nuclear-cytoplasm shuttling protein liketion on CSR so severe? One speculation is that UNG
may have another function than U removal that is impor- APOBEC-1.
Dispensability of U Removal Activity of UNG in CSR.tant to CSR.
Supporting Evidence for RNA Editing Hypothesis Severe reduction in CSR efficiency in UNG-deficient B
cells strongly indicates that UNG plays a role in CSR.Requirements of De Novo Protein Synthesis for Cleav-
age. One of the distinctions between DNA deamination Since U removal is the only known enzymatic activity
of UNG, this finding was thought to support involvementand RNA editing hypotheses resides in requirement of
translation of mRNA edited by AID (Figure 2). It is there- of U generation by AID-mediated DNA deamination in
CSR. If UNG is required for U removal activity to triggerfore important to test whether new protein synthesis is
required for CSR and SHM in addition to the AID protein DNA cleavage by base excision repair mechanism, UNG
inhibition should block DNA cleavage. This possibilitysynthesis. The study was done using a fusion protein
of AID and the hormone binding domain of the estrogen was tested by combining a specific inhibitor protein of
UNG, Ugi, and -H2AX focus formation to monitor DSBreceptor (AIDER) to avoid the effect of a protein synthe-
sis inhibitor on synthesis of AID protein (Doi et al., 2003). in activated B cells (N. Begum and T.H., submitted).
When DNA binding activity of UNG was blocked by ex-AIDER associates with heat shock protein 90 and re-
mains inactive unless a hormone analog, tamoxiphen, pression of Ugi, CSR in CH12F3-2 B cells was almost
completely blocked. However, DNA cleavage assesseddissociates heat shock protein 90 to activate AID activ-
ity. AID-deficient spleen B cells were infected by retro- by the -H2AX focus formation at the IgH locus was not
inhibited by Ugi expression. The results strongly indicatevirus containing AIDER and then a protein synthesis
inhibitor (cycloheximide) was added before and after that UNG is not involved in the DNA cleavage step of
CSR but rather repair stages that include exonucleolyticactivation of AIDER by tamoxiphen. Cycloheximide,
when added before activation of AIDER, almost com- cleavage, DNA synthesis, and DNA ligation.
Consistently, studies on several UNG mutants, whichpletely blocked CSR. However, inhibition by cyclohexi-
mide when added after activation of AIDER was much are devoid of U removal activity, rescued CSR in UNG/
B cells, indicating that U removal activity of UNG isless significant. The results strongly indicate de novo
protein synthesis is required in the early phase of AID- not required for CSR. These results indicate that some
unknown function but not U removal activity of UNGdependent CSR.
The next obvious question is whether protein synthe- is required for repair stages in CSR. This conclusion
explains the drastic difference in the effects on CSRsis is required before or after the DNA cleavage. Very
recently, we found that de novo protein synthesis is and the general mutation frequency in UNG null mice
described above. Human B cells with UNG null muta-required before the cleavage step, using histone -H2AX
focus formation as a marker of DNA cleavage (N. Begum tions that were previously reported to be defective in
activation induced DSB by the linker-mediated PCRand T.H., submitted). AID-dependent -H2AX focus for-
mation in the IgH locus of AIDER expressing CH12F3-2 assay (Imai et al., 2003). The difference from the above
observation in mouse could be ascribed to the detectioncells was blocked when protein synthesis was inhibited
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method of DSB or stimulation conditions. DSB detected tivity in E. coli. The results can be most easily explained
by linker mediated PCR in activated B cells was reported by the presence of cofactor that plays a specific role in
to be not always AID dependent (Bross et al., 2002; CSR but not in SHM. Subsequently, it was found that
Catalan et al., 2003; Faili et al., 2002; Papavasiliou and other point mutations located in the N-terminal part of
Schatz, 2002; Rush et al., 2004). AID almost completely destroyed SHM activity but re-
Role of UNG at the Repair Stage in CSR tained CSR activity (Shinkura et al., 2004). Thus, AID
The tertiary structures of human UNG and its complex appears to interact with at least two separate cofactors,
with Ugi have been solved (Mol et al., 1995a, 1995b). each specifically required to either SHM or CSR. The
Human and mouse UNG are 95% homologous. UNG function of these cofactors remains unknown, but it is
has the N-terminal PCNA/replication protein A (RPA) most likely that they are involved in recognition of AID
binding domain and the C-terminal catalytic domain that target, RNA, or DNA. Although AID per se can deaminate
interacts with U and DNA. Ugi binds to UNG tightly and C in mRNA or DNA, actual enzymatic activity of AID may
blocks its interaction with DNA. The primary function of require cofactors that target specific bases in nucleic
UNG is removal of misincorporated U opposite to ade- acids. In the absence of such cofactors, AID may attack
nine during replication (Parikh et al., 2000). UNG in the DNA or RNA in an uncoupled fashion as shown in E. coli
PCNA complex at the replication folk scans newly syn- and in vitro.
thesized DNA to flip out U and remove it by hydrolysis. Although AID is likely involved in cleavage of both V
Removal of U by UNG is followed by strand cleavage and S regions, CSR and SHM take place independently
by AP endonuclease. The AP site is removed and re- in activated B cells, in which both V and CH genes are
paired by gap-filling activity of DNA polymerase . How- transcribed. The results suggest that V and S regions
ever, the initial sensor of U in the interphase DNA is not must be recognized distinctively and AID itself is unlikely
well understood (Krokan et al., 2002). to distinguish V and S region DNA. According to DNA
It is clear that UNG is important but not essential to deamination hypothesis, AID requires CSR- and SHM-
CSR because of the residual switching activity in UNG/ specific cofactors, which can recognize S and V region
mice (Rada et al., 2002). DNA binding activity of UNG DNA, respectively. RNA editing hypothesis predicts that
appears to be critical, because Ugi almost completely separate DNA endonucleases generated by RNA editing
blocks UNG as well as CSR. Although the role of UNG distinguish V and S regions and that AID cofactors spe-
in CSR remains elusive, the enzymatic activity of UNG cific to SHM and CSR recognize different mRNAs to be
is not required for CSR. We speculate that UNG may be edited by AID.
involved in recruiting either DNA synthesis apparatus, The evidence for DNA deamination hypothesis in SHM
including error-prone polymerases or other members of is increase in the transition rate in C/G mutations, namely
the repair machinery. It is also possible that UNG plays C to T or G to A in UNG-deficient B cells. However, UNG
a role in holding the cleaved ends. Indeed, UNG without deficiency does not reduce SHM frequency at all (Rada
U removal activity is required for replication of vaccinia et al., 2002). On the other hand, MSH2-deficient mice
virus DNA (De Silva and Moss, 2003). A similar puzzle show considerable reduction of SHM frequency in addi-
was reported for the DNA-PKcs null mutation and the tion to a strong bias of target bases to GC (Martin et
SCID mutation of DNA-PKcs. The SCID mutant mouse al., 2003; Phung et al., 1998; Rada et al., 1998). It is not
has no catalytic activity of DNA-PKcs but shows about clear whether mutated base specificity shift reflects a
50% CSR activity for all isotypes (Bosma et al., 2002). direct effect of UNG or MMR, because mutated base
By contrast, B cells of mice lacking DNA-PKcs cannot specificity can be modulated by many factors, including
switch to any isotypes except for IgG1 with 30%–50% choices of error-prone polymerases. Both UNG and
efficiency of wild-type (Manis et al., 2002), suggesting MSH3/6 have domains to interact with PCNA, implying
that DNA-PKcs protein but not its enzymatic activity is that they may be involved in recruitment of DNA synthe-
important. Here, again, DNA-PKcs may play an essential sis machinery. Change of mutation base specificity in
role as recruiter of NHEJ repair proteins. Furthermore,
UNG- and MSH2-deficient mice can be explained by the
B cells of ATPase-defective MSH2 knockin mice show
hypothesis that they recruit different error-prone DNA
milder reduction in CSR as compared with those of
polymerases. It remains to be determined whether UNGMSH2/mice (Martin et al., 2003). Once again, dissocia-
plays a role in SHM as a U removal enzyme or as ation of CSR phenotypes is evident between loss of the
recruiter of other DNA repair machinery.enzymatic activity and of protein per se.
Distinction of CSR and SHM by Separate Cofactors
Summary and PerspectiveThe loss-of-function mutations of AID for CSR in HIGM2
Recent data clearly indicate that U removal activity ofsyndrome patients scatter from the N terminus to the C
UNG is not required for CSR and that another functionterminus of the 198 amino acid residue AID protein (Ta
of UNG is involved in the repair stage of CSR. Althoughet al., 2003). Such observation raises two possibilities:
these results do not exclude DNA deamination itself,(1) this protein is very labile and a point mutation of
the mechanism of DNA cleavage proposed by DNA de-every part of the molecule destroys the tertiary structure
amination hypothesis has to be reconsidered. Takenof the AID protein and (2) AID interacts with other pro-
together with other recent findings, including de novoteins at different parts of the molecule. To explore this
protein synthesis requirement for cleavage, it is easierpossibility, we assayed in vitro CSR and SHM activities
to explain AID-induced DNA cleavage according to RNAof the AID mutant cDNAs of HIGM2. Most of them are
editing hypothesis.loss-of-function mutations of both activities. However,
The most likely scenario for DNA cleavage based onthree mutations (truncations or replacement) of the C
the current data is as follows (Figure 3). AID together withterminus of AID abolish CSR activity but retain SHM
activity. Such mutants also retain DNA deamination ac- class switch-specific cofactor or SHM-specific cofactor
Review
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Figure 3. The Updated RNA Editing Model for CSR and SHM
AID deaminates two mRNAs through recognition by SHM- and CSR-specific cofactors, and mRNAs thus edited are translated to a mutator
and recombinase, respectively. SSB on V gene recruits error-prone repair system in association with MMR and UNG. Replication fixes newly
introduced mutations. DSB on two S regions are recognized damage sensors, giving rise to H2AX focus formation. DNA ends with H2AX
foci recruit NHEJ repair (Ku 70, 80, DNA-PKcs, XRCC4, lygase IV), UNG, MMR, and error-prone repair system. Exonuclease and polymerase
activities make DNA blunt ends ready to NHEJ repair. X and Y are unknown enzymes involved in repair of V and S regions, respectively.
M, mutation.
edits yet unidentified mRNAs, generating mRNAs en- prone polymerases (Diaz et al., 2001; Yavuz et al., 2002;
Zan et al., 2001; Zeng et al., 2001).coding putative endonucleases, specific to either V or
S region DNA. Both V- and S-specific endonucleases Obviously, there are many questions to be solved.
The key question is how two endonucleases can distin-introduce nick on the target DNA. S-specific endonucle-
ase introduces nicks rather frequently, generating stag- guish V and S regions. Since there is no primary se-
quence specificity, it is likely that these two endonucle-gered nick DSB. By contrast, V-specific endonuclease
introduces nick rarely and generates SSB. After such ases recognize secondary structures, which may be
formed during active transcription of these loci. Suchcleavage, both V and S regions require repair systems
to complete SHM and CSR, respectively. Cleaved S re- recognition specificity will be clarified by isolation of
target mRNA of AID. If this RNA editing scenario is veri-gion is monitored by DSB sensor protein ATM/ATR and
DNA-PKcs, which phosphorylate H2AX to initiate NHEJ fied by isolation of target mRNAs, genetic modifications
in the immune system consist of tremendously complexmechanism. During this process, many other proteins,
including MMR, exonuclease I, UNG, and DNA polymer- layers of informational alteration systems, i.e., RNA edit-
ing, DNA recombination, and point mutations. It is reallyases, are most likely recruited. UNG is required not as
its U removal activity but probably as a recruiting protein fascinating how the immune system has involved such
complex layers of system to amplify genetic informationof other enzymes. For SHM, the repair process is proba-
bly simpler and does not depend on NHEJ (Bemark et encoded in the genome.
al., 2000). SHM is severely affected by MMR and UNG
deficiency. Specificity of mutated bases may depend
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